SEI Investments
AQST icon

SEI Investments’s Aquestive Therapeutics AQST Stock Holding History

SEI Investments’s Portfolio AQST Stock Details AQST Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$114K Buy
27,350
+2,505
+10% +$10.5K ﹤0.01% 3163
2026
Q1 		$103K Sell
24,845
-173,143
-87% -$703K ﹤0.01% 3091
2025
Q4 		$1.28M Buy
+197,988
New +$1.23M ﹤0.01% 2062

Other funds holding AQST

BCM
Bratton Capital Management Fort Worth, Texas $40.8M AUM 25.68% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
RI
RTW Investments New York $11.7B AUM 174.13% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Federated Hermes
Federated Hermes Pittsburgh, Pennsylvania $69.6B AUM 42.52% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
SB
Samsara BioCapital Palo Alto, California $1.22B AUM 242.83% 1-Year Est. Return
Bank of America
Bank of America Charlotte, North Carolina $1.55T AUM 33.47% 1-Year Est. Return
SCM
Sio Capital Management New York $604M AUM 96.57% 1-Year Est. Return

SEI Investments's AQST Position: Q2 2026 in Review

SEI Investments increased its Aquestive Therapeutics (AQST) stake by 10% in Q2 2026, buying an estimated $10.5K and bringing the position to 27,350 shares worth $114K. The position accounts for ﹤0.01% of the portfolio, ranked #3163.

SEI Investments first reported a position in AQST in Q4 2025 and has held it in 3 quarters since. The position peaked at $1.28M in Q4 2025. 184 funds tracked by Wall St. Rank hold AQST as of Q2 2026.

  • SEI Investments held 27,350 shares of Aquestive Therapeutics worth $114K as of Q2 2026.
  • SEI Investments bought 2,505 Aquestive Therapeutics shares in Q2 2026, an estimated $10.5K.
  • Aquestive Therapeutics made up ﹤0.01% of SEI Investments's portfolio in Q2 2026, its #3163 holding.
  • SEI Investments first reported a position in Aquestive Therapeutics in Q4 2025 and has held it in 3 quarters since.
  • SEI Investments's Aquestive Therapeutics position peaked at $1.28M in Q4 2025.
  • 184 funds tracked by Wall St. Rank held Aquestive Therapeutics as of Q2 2026.

Based on SEI Investments's 13F filing for Q2 2026, filed 14 Aug 2026.